New or worsening peripheral neuropathy could demand a lowered dose or altered dose plan (see Dosage Modification) Remedy results in peripheral neuropathy (predominantly sensory); however, cases of intense sensory and motor peripheral neuropathy are actually claimed 3 mg/m2 dose. In patients with numerous myeloma, the Cmax of bortezomib followig subcutaneous https://barryr099epz1.wikipublicity.com/user